| Financial Year |
March 31 2023 |
| Monetary Funds |
795,322,583.99 |
| Held-for-trading Financial Assets |
379,614,660.23 |
| Notes Receivable |
17,175,113.43 |
| Accounts Receivable |
619,227,194.81 |
| Advances to Suppliers |
415,243,058.65 |
| Other Receivables |
65,399,812.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
721,088,298.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
28,728,243.18 |
| Other Current Assets |
48,028,309.28 |
| Total Current Assets |
3,149,773,491.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
10,547,270.02 |
| Long-term Equity Investment |
54,405,259.46 |
| Investment Properties |
40,262,250.61 |
| Fixed Assetes |
115,051,650.87 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
155,419,001.86 |
| R&D expenses |
110,723,856.98 |
| Goodwill |
88,767,419.43 |
| Long-Term Deferred and Prepaid Expenses |
20,177,035.10 |
| Deferred Income Tax Assets |
91,571,742.14 |
| Other Non-Current Assets |
585,898,821.87 |
| Sub-Total of Non-Current Assets |
1,353,289,358.92 |
| Total Assets |
4,503,062,850.18 |
| Short-Term Loans |
549,566,285.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
347,559,638.14 |
| Accounts Payable |
148,107,506.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
35,939,158.21 |
| Taxes Payable |
43,997,335.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
107,724,496.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
184,966,333.71 |
| Other Current Liabilities |
7,524,154.49 |
| Sub-Total of Current Liabilities |
1,594,290,265.94 |
| Long-term Loans |
15,379,994.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
32,288,876.99 |
| Deferred Income Tax Liabilities |
12,515,183.68 |
| Other Non-Current Liabilities |
135,378,147.59 |
| Sub-Total of Non-Current Liabilities |
207,454,954.96 |
| Total Liabilities |
1,801,745,220.90 |
| Paid-In Capital(Or Share Stock) |
1,255,827,674.00 |
| Capital Surplus |
2,686,438,271.87 |
| Surplus Reserve |
64,922,705.84 |
| LESS:Treasury Stock |
22,961,400.00 |
| Undistributed Profits |
-1,444,261,237.38 |
| Minority Stockholder's Interest |
172,776,974.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,528,540,654.51 |
| Owner's Equity（Stockholder's Equity） |
2,701,317,629.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,503,062,850.18 |
